About 3,300 women a year may benefit from decision to approve ribociclib

Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance.

The National Institute for Health and Care Excellence (Nice) has approved the drug – ribociclib , also known as Kisqali – for routine use by the NHS in England and Wales. It said around 3,300 women a year with advanced breast cancer could benefit from the decision.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

What is it about Viktor Orbán that attracts so many rightwing sycophants? | Nick Cohen

Hungary’s leader and Fox News are natural bedfellows in peddling paranoia politics…

There is a huge difference between my partner’s financial situation and mine. How can this be bridged? | Leading questions

Money can be so divisive, writes advice columnist Eleanor Gordon-Smith. When you…

‘There’s risk in everything, right?’ The serendipity and agony of dating your neighbour

Finding love across the back fence or apartment corridor is a high…

Arizona Sharpie votes

sharpies on ballots